医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Children’s Hospital Los Angeles and Mongolia’s Flagship Pediatric Medical Facility Celebrate 20 Years of Collaboration

2015年04月01日 PM10:00
このエントリーをはてなブックマークに追加


 

LOS ANGELES

Leaders from Children’s Hospital Los Angeles (CHLA) and the National Center for Maternal and Child Health (NCMCH), Mongolia’s flagship pediatric medical facility, marked 20 years of institutional collaboration Tuesday with a special “telemedicine” program and celebration honoring past accomplishments and outlining future efforts to better the health care of Mongolian children.

(L-R) Children's Hospital Los Angeles physicians David Warburton, Richard MacKenzie and Stuart Siege ...

(L-R) Children’s Hospital Los Angeles physicians David Warburton, Richard MacKenzie and Stuart Siegel were guest speakers at an event celebrating the 20-year pediatric health care partnership between CHLA and the National Center for Maternal and Child Health in Mongolia. (Photo: Business Wire)

The physicians gathered at their respective institutions in Los Angeles and Ulaanbaatar, Mongolia’s capital, and communicated via telemedicine conference. Tuesday’s event began at 4:30 pm PDT and at 8:30 am Mongolia time. “This partnership has helped raise the standard of care for children in Mongolia,” says Richard MacKenzie, MD, medical director of the Center for Global Health at Children’s Hospital Los Angeles, and deputy director of the hospital’s Division of Adolescent Medicine. “This event commemorates two decades of working together to achieve this goal and establishes a new collaborative agreement to build on efforts in education, telemedicine, research and physician exchange programs.”

“CHLA faculty and residents have provided important assistance to NCMCH and its affiliated medical school in the development of their pediatric clinical programs and training, as well as consulting on many patients over the past 20 years,” says Stuart E. Siegel, MD, director of the Center for Global Health at CHLA. “It has been a dream of ours to provide this service from CHLA and now the NCMCH has the tele health technology capacity that will allow us to contribute and pass on our program development and care more efficiently.”

Since the collaboration began in 1995, instigated by academician Arnold Springer, PhD, a retired Cal State Long Beach professor and an authority on Russia, the health care of Mongolian children has benefited from the care and training by CHLA physicians traveling to NCMCH at their own expense to treat cases in children’s cancer, cardiology, infectious diseases, intensive care, pulmonology, gastroenterology, pediatric general and orthopedic surgery, endocrinology, adolescent medicine and rheumatology.

Enkhtur Shonkhuuz, MD, MPM, PhD, clinical professor of Pediatrics and Director-General of the NCMCH, says that since the first visit by the CHLA team, Мongolia has made dramatic progress in improving child health. He reported that the under-age-five mortality rate per 1,000 live births was 62.4 in 1995 and declined to 18.4 in 2014. Infant mortality rate per 1,000 live births was 44.6 in 1995 and declined to 15.3 in 2014. “Of course, this progress is not only due to the collaboration, but we can say there has been a big contribution by the CHLA team in capacity building of NCMCH, which is a key player in reducing child mortality in the country,” he says.

The relationship also has nurtured a research component. In 2014, scientists from Los Angeles and Ulaanbaatar published a study that reported that burning coal for domestic heating may contribute to early fetal death. “CHLA and colleagues in government and academia in Mongolia are expending concerted efforts to improve stove efficiency and to educate the public about correct and more efficient lighting and heating methods,” says study leader David Warburton, OBE, DSc, MD, MMM, FRCP, FRCS, FRCPCH, professor of Pediatrics and Surgery at The Saban Research Institute of Children’s Hospital Los Angeles. “Mongolians are wonderful, smart, warm people,” says Warburton. “They listen to and appreciate our advice and are acting on it as gross domestic product has risen and resources become increasingly available in their country. We have seen impressive changes over the past decades and now look forward to further collaboration.”

Recently, the relationship between the institutions has been reinvigorated by Mongolia’s successful infrastructure additions and infection control protocols at the NCMCH. This now allows CHLA physicians to work with colleagues to treat more complex cases. “Over the past 20 years, we have helped to guide the NCMCH into providing improved pediatric care through development of knowledge, skills and hospital facilities,” MacKenzie says. “We now stand prepared to further assist as they develop the expertise and technology to provide advanced pediatric and surgical care practiced in the 21st century.”

About Children’s Hospital Los Angeles

Children’s Hospital Los Angeles has been named the best children’s hospital on the West Coast and among the top five in the nation for clinical excellence with its selection to the prestigious U.S. News & World Report Honor Roll. Children’s Hospital is home to The Saban Research Institute, one of the largest and most productive pediatric research facilities in the United States. Children’s Hospital is also one of America’s premier teaching hospitals through its affiliation since 1932 with the Keck School of Medicine of the University of Southern California.

For more information, visit CHLA.org and follow us on ResearCHLAblog.org.

Photos/Multimedia Gallery Available: http://www.businesswire.com/multimedia/home/20150401005242/en/

CONTACT

Contact: Lorenzo Benet, lbenet@chla.usc.edu.
323-361-4823

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • ADCセラピューティクスが当社の新規抗体薬物複合体ADCT-402の第I相中間データを発表
  • Vedanta Biosciences Granted Four New U.S. Patents Expanding Coverage for Compositions and Methods of Use for Therapeutics Based on Microbiome-Derived Bacterial Consortia
  • Daiichi Sankyo and Puma Biotechnology Announce Research Collaboration with Major Cancer Center in HER2-Mutated Cancer
  • 武田和Seattle Genetics呈报3期ECHELON-1临床试验的阳性数据,该试验评估ADCETRIS® (brentuximab vedotin)用于晚期霍奇金淋巴瘤的一线治疗
  • ADCセラピューティクスが当社の新規抗体薬物複合体ADCT-301の第I相中間データを発表